| 1 |
任成山，钱桂生. 慢性阻塞性肺疾病发病机制研究现状与展望[J/CD]. 中华肺部疾病杂志：电子版，2009, 2(2):104-115.
|
| 2 |
GOLD (2015). Global Strategy for the Diagnosis, Management, and prevention of chronic obstructive pulmonary disease. Available from:
URL
|
| 3 |
姜艳平，赵云峰，赵秋良. CT对慢性阻塞性肺疾病临床评估的价值[J]. 临床肺科杂志，2014, 19(9): 1684-1686.
|
| 4 |
黄俊芳，王广发. 慢性阻塞性肺病全球倡议慢性阻塞性肺病指南(2013更新版)解读[J/CD]. 中国医学前沿杂志：电子版，2013, 5(3): 58-60.
|
| 5 |
McLaughlin VV, Archer SL, Badesch DB, et al. ACCF/AHA 2009 expert consensus document on pulmonary hypertension: a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents and the American Heart Association: developed in collaboration with the American College of Chest Physicians, American Thoracic Society, Inc., and the Pulmonary Hypertension Association[J]. Circulation, 2009, 119(16): 2250-2294.
|
| 6 |
Schulman LL, Lennon PF, Wood JA, et al. Pulmonary vascular resistance in emphysema[J]. Chest, 1994, 105(3): 798-805.
|
| 7 |
Wells JM, Dransfield MT. Pathophysiology and clinical implications of pulmonary arterial enlargement in COPD [J]. Int J Chron Obstruct Pulmon Dis, 2013, 8: 509-521.
|
| 8 |
Hurdman J, Condliffe R, Elliot CA, et al. Pulmonary hypertension in COPD: results from the ASPIRE registry [J]. Eur Respir J, 2013, 41(6): 1292-1301.
|
| 9 |
Yildiz P, Oflaz H, Cine N, et al. Gene polymorphisms of endothelial nitric oxide synthase enzyme associated with pulmonary hypertension in patients with COPD[J]. Respir Med, 2003, 97(12): 1282-1288.
|
| 10 |
Tuder RM, Flook BE, Voelkel NF. Increased gene expression for VEGF and the VEGF receptors KDR/Flk and Flt in lungs exposed to acute or to chronic hypoxia. Modulation of gene expression by nitric oxide[J]. J Clin Invest, 1995, 95(4): 1798-1807.
|
| 11 |
Matura LA, Ventetuolo CE, Palevsky HI, et al. Interleukin-6 and tumor necrosis factor-α are associated with quality of life-related symptoms in pulmonary arterial hypertension[J]. Ann Am Thorac Soc, 2015, 12(3): 370-375.
|
| 12 |
Hashimoto-Kataoka T, Hosen N, Sonobe T, et al. Interleukin-6/interleukin-21 signaling axis is critical in the pathogenesis of pulmonary arterial hypertension[J]. Proc Natl Acad Sci U S A, 2015, 112(20): E2677-2686.
|
| 13 |
Arcasoy SM, Christie JD, Ferrari VA, et al. Echocardiographic assessment of pulmonary hypertension in patients with advanced lung disease[J]. Am J Respir Crit Care Med, 2003, 167(5): 735-740.
|
| 14 |
Laaban JP, Diebold B, Zelinski R, et al. Noninvasive estimation of systolic pulmonary artery pressure using Doppler echocardiography in patients with chronic obstructive pulmonary disease[J]. Chest, 1989, 96(6): 1258-1262.
|
| 15 |
Washko GR, Parraga G, Coxson HO. Quantitative pulmonary imaging using computed tomography and magnetic resonance imaging[J]. Respirology, 2012, 17(3): 432-444.
|
| 16 |
Jones PW, Harding G, Berry P, et al. Development and first validation of the COPD Assessment[J]. Eur Respir J, 2009, 34(3): 648-654.
|
| 17 |
荆志成. 六分钟步行距离试验的临床应用[J]. 中华心血管病杂志，2006, 34(4): 381-384.
|
| 18 |
Ng CS, Wells AU, Padley SP. A CT sign of chronic pulmonary arterial hypertension: the ratio of main pulmonary artery to aortic diameter[J]. J Thorac Imaging, 1999, 14(4): 270-278.
|
| 19 |
Wells JM, Washko GR, Han MK, et al. Pulmonary arterial enlargement and acute exacerbations of COPD[J]. N Engl J Med, 2012, 367(10): 913-921.
|
| 20 |
刘鹏，郭顺林，雷军强，等. 慢性阻塞性肺疾病相关肺动脉高压的多层螺旋CT评价[J]. 中华结核和呼吸杂志，2012, 35(4): 264-268.
|
| 21 |
Devaraj A, Wells AU, Meister MG, et al. Detection of pulmonary hypertension with multidetector CT and echocardiography alone and in combination[J]. Radiology, 2010, 254(2): 609-616.
|
| 22 |
Iyer AS, Wells JM, Vishin S, et al. CT Scan-Measured Pulmonary Artery to Aorta Ratio and Echocardiography for Detecting Pulmonary Hypertension in Severe COPD[J]. Chest, 2014, 145(4): 824-832.
|
| 23 |
丁薇，赵伟，熊伟，等. 胸部CT测定肺动脉直径与主动脉直径比值判断慢性阻塞性肺疾病急性加重的临床价值[J]. 上海医学，2015, 38(6): 523-527.
|